ACLARION, INC. Additional Paid in Capital, Preferred Stock
ACLARION, INC. (ACON) had Additional Paid in Capital, Preferred Stock of $0 as of 2022-12-31, per its 10-K/A filed 2023-06-12.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:AdditionalPaidInCapitalPreferredStock · last filed 2023-06-12
- 2022-12-31: Additional Paid in Capital, Preferred Stock $0.00.
- 2022-09-30: Additional Paid in Capital, Preferred Stock $0.00.
- 2022-06-30: Additional Paid in Capital, Preferred Stock $0.00.
- 2022-03-31: Additional Paid in Capital, Preferred Stock $7.10M.
| Period end | Additional Paid in Capital, Preferred Stock |
|---|---|
| 2022-12-31 | $0.00 10-K/A · filed 2023-06-12 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 |
| 2022-03-31 | $7.10M 10-Q · filed 2022-06-06 |
| 2021-12-31 | $7.10M 10-K/A · filed 2023-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |